- Pure Extracts is working with Dr. Alexander MacGregor on development of mushroom products, including some combined with CBD.
- MacGregor is widely renowned as pharmaceutical science inventor, expert in pharmaceutical technology and novel drug-delivery systems.
- Pure Extracts is focused on expansion of its cannabis extraction business model to include mushroom formulations.
Pure Extracts Technologies (CSE: PULL) has established a key collaborative relationship with an expert in translating pharmaceutical knowledge into a sustainable business. The plant-based extraction company, which is focused on cannabis, hemp and the rapidly emerging functional mushroom sector, is working closely with Dr. Alexander MacGregor on developing quality cannabis and mushroom formulations (https://cnw.fm/i9Tii).
Calling MacGregor a “key scientific advisor,” Pure Extracts announced that it is working with the pharmaceutical and biopharmaceutical expert on the development of CBD-infused mushroom wellness products as well as on researching psilocybin extraction methodologies. These efforts are focused on planning for Pure Extracts’ successful entrance into the psychedelic mushroom extraction space.
MacGregor serves as the dean of faculty, distinguished professor of biopharmaceutics and current president of the Toronto Institute of Pharmaceutical Technology (“TIPT”). TIPT is North America’s premier post-graduate institute of pharmaceutical sciences, technology and research. In addition, MacGregor is the CEO of TIPT’s parent company, Transpharm Canada Inc. Transpharm Canada has received a Health Canada Drug Establishment License, a Cannabis Drug License and a Dealer’s License issued under the Controlled Drugs and Substances Act (“CDSA”). Licensed to possess psychedelic drug compounds, Transpharm Canada has extensive expertise in conducting cannabis testing, clinical trials and drug development.
MacGregor is widely renowned as a pharmaceutical science inventor and an expert in pharmaceutical technology and novel drug-delivery systems; he is also the holder of several global patents in the field of medical treatments and pharmaceutical drug delivery technologies. His inventions have been key in the discovery of groundbreaking therapeutic drugs for the management of diabetes and the treatment of cancer, systemic infections and post-operative pain. MacGregor has served as a consultant to several multinational pharmaceutical companies, including GlaxoSmithKline, Valeant, Teva, Patheon, Sun Pharma and Beijing Double-Crane Pharma.
Pure Extracts is focused on the expansion of its business model to include mushroom formulations through the use of extraction processes that have proven compatible with its existing infrastructure (https://cnw.fm/lbdpj). The company is looking to leverage its expertise to develop high bio-available products and novel delivery methodologies including pills, capsules and edibles.
Pure Extracts is also eyeing the opportunity to become a significant extraction partner for the commercialization of new functional mushroom products. In fact, the company has already taken steps in that direction; the Company recently signed a letter of intent with PURICA(TM), one of Canada’s leading functional mushroom wellness brands, to partner together to produce CBD-enhanced mushroom products.
Headquartered in Pemberton, British Columbia, Pure Extracts is a plant-based extraction company that appears ideally positioned to be the dominant extraction company in the rapid development and commercialization of novel functional mushroom products.
For more information, visit the company’s website at www.PureExtractsCorp.com.
NOTE TO INVESTORS: The latest news and updates relating to PULL are available in the company’s newsroom at https://cnw.fm/PULL
About HempWire
HempWire (HW) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWire (HW) is where HEMP news, content and information converge.
To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.hempwire.com
Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/Disclaimer
Do you have a questions or are you interested in working with HW? Ask our Editor
HempWire (HW)
Denver, Colorado
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net
HempWire is part of the InvestorBrandNetwork.
